Fundz

Who to call at Alnylam Pharmaceuticals, and when

Fundz watches for the moments Alnylam Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Alnylam Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alnylam Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alnylam Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchAlnylam Pharmaceuticals announces preliminary fourth quarter and full year 2024 global net product revenues and outlines 2025 goals.

Jan 12, 2025
CambridgeBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Product Description

Alnylam Pharmaceuticals reported its preliminary global net product revenues for its key products, totaling over $1.6 billion for 2024, marking a 33% increase. The company also shared its guidance for 2025, indicating expectations for significant growth with new product launches in their pipeline.

Company Information

Company

Alnylam Pharmaceuticals

Location

Cambridge, Massachusetts, United States

About

Alnylam Pharmaceuticals, Inc. is a leading RNAi therapeutics company focused on developing novel medicines to treat genetically defined diseases. The company is committed to bringing innovative treatments to patients suffering from serious conditions. Their investigational product vutrisiran is designed to treat transthyretin amyloidosis with cardiomyopathy, aiming to improve patient outcomes through advanced therapeutic approaches.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alnylam Pharmaceuticals ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Pushkal hidden

hidden
hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Alnylam Pharmaceuticals's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Alnylam Pharmaceuticals shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.